Literature DB >> 27773783

Chitosan oligosaccharide: Biological activities and potential therapeutic applications.

Chatchai Muanprasat1, Varanuj Chatsudthipong2.   

Abstract

Chitosan oligosaccharide (COS) is an oligomer of β-(1➔4)-linked d-glucosamine. COS can be prepared from the deacetylation and hydrolysis of chitin, which is commonly found in the exoskeletons of arthropods and insects and the cell walls of fungi. COS is water soluble, non-cytotoxic, readily absorbed through the intestine and mainly excreted in the urine. Of particular importance, COS and its derivatives have been demonstrated to possess several biological activities including anti-inflammation, immunostimulation, anti-tumor, anti-obesity, anti-hypertension, anti-Alzheimer's disease, tissue regeneration promotion, drug and DNA delivery enhancement, anti-microbial, anti-oxidation and calcium-absorption enhancement. The mechanisms of actions of COS have been found to involve the modulation of several important pathways including the suppression of nuclear factor kappa B (NF-κB) and mitogen-activated protein kinases (MAPK) and the activation of AMP-activated protein kinase (AMPK). This review summarizes the current knowledge of the preparation methods, pharmacokinetic profiles, biological activities, potential therapeutic applications and safety profiles of COS and its derivatives. In addition, future research directions are discussed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chitin; Chitosan; Chitosan oligosaccharide; Drug discovery; Polymers

Mesh:

Substances:

Year:  2016        PMID: 27773783     DOI: 10.1016/j.pharmthera.2016.10.013

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  72 in total

Review 1.  Chitin and chitosan: biopolymers for wound management.

Authors:  Rita Singh; Kirti Shitiz; Antaryami Singh
Journal:  Int Wound J       Date:  2017-08-10       Impact factor: 3.315

2.  Biochemical characterization and cleavage pattern analysis of a novel chitosanase with cellulase activity.

Authors:  Haipeng Su; Jianan Sun; Wenqin Chu; Bing Yuan; Xiangzhao Mao
Journal:  Appl Microbiol Biotechnol       Date:  2022-02-17       Impact factor: 4.813

3.  Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.

Authors:  Xuelei Yin; Yingying Chi; Chuanyou Guo; Shuaishuai Feng; Jinhu Liu; Kaoxiang Sun; Zimei Wu
Journal:  Pharm Res       Date:  2017-07-19       Impact factor: 4.200

Review 4.  Bioconversion of Chitin to Bioactive Chitooligosaccharides: Amelioration and Coastal Pollution Reduction by Microbial Resources.

Authors:  Manish Kumar; Amandeep Brar; V Vivekanand; Nidhi Pareek
Journal:  Mar Biotechnol (NY)       Date:  2018-04-10       Impact factor: 3.619

5.  A temperature-induced chitosanase bacterial cell-surface display system for the efficient production of chitooligosaccharides.

Authors:  Qianqian Li; Tuantuan Wang; Yangzhi Ye; Shimin Guan; Baoguo Cai; Shuo Zhang; Shaofeng Rong
Journal:  Biotechnol Lett       Date:  2021-05-16       Impact factor: 2.461

Review 6.  Microbial chitinases: properties, enhancement and potential applications.

Authors:  Eman Zakaria Gomaa
Journal:  Protoplasma       Date:  2021-01-22       Impact factor: 3.356

Review 7.  Can functional oligosaccharides reduce the risk of diabetes mellitus?

Authors:  Di Zhu; Qiaojuan Yan; Jun Liu; Xia Wu; Zhengqiang Jiang
Journal:  FASEB J       Date:  2019-08-15       Impact factor: 5.834

8.  Chitosan oligosaccharide modified liposomes enhance lung cancer delivery of paclitaxel.

Authors:  Yun-Qiu Miao; Ming-Shu Chen; Xin Zhou; Lin-Miao Guo; Jing-Jing Zhu; Rui Wang; Xin-Xin Zhang; Yong Gan
Journal:  Acta Pharmacol Sin       Date:  2021-01-19       Impact factor: 7.169

9.  Pretreatment with chitosan oligosaccharides attenuate experimental severe acute pancreatitis via inhibiting oxidative stress and modulating intestinal homeostasis.

Authors:  Qi-Xiang Mei; Jun-Hui Hu; Ze-Hua Huang; Jun-Jie Fan; Chun-Lan Huang; Ying-Ying Lu; Xing-Peng Wang; Yue Zeng
Journal:  Acta Pharmacol Sin       Date:  2021-01-25       Impact factor: 7.169

Review 10.  Potential Applications of Chitosan-Based Nanomaterials to Surpass the Gastrointestinal Physiological Obstacles and Enhance the Intestinal Drug Absorption.

Authors:  Nutthapoom Pathomthongtaweechai; Chatchai Muanprasat
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.